B-cell small lymphocytic lymphoma

• A Phase 3 Study of DZD8586 versus Investigator’s Choice in r/r CLL/SLL Recruiting
  2025-522669-32-00 5 2025-12-18 "Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymph"
• A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a Bcell Lymphoma-2 Inhibit … Recruiting
  2025-521088-10-00 4 2025-10-23 "Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)"
• A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration ( … Recruiting
  2023-510294-34-00 5 2025-06-12 "small lymphocytic lymphoma (SLL)"
• Multi-cohort Study to Customize Ibrutinib Treatment Regimens for Patients with Previously Untreated Chronic Lymphocytic Leukemia TAILOR Recruiting
  2023-504044-34-00 4 2024-04-17 "Untreated Chronic Lymphocytic Leukemia"
• A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies Recruiting
  2023-510541-25-00 1 2023-10-09 "Relapsed/Refractory B-cell Malignancies"
• A Phase III Open-Label Trial of Acalabrutinib Plus Venetoclax versus Venetoclax plus Obinutuzumab in Previously Untreated Chronic Lymphocyti … Recruitment ended
  2023-505866-27-00 5 2022-10-28 "Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma"
• Study of Rapcabtagene autoleucel (YTB323) in adult patients with CLL/SLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL Recruitment ended
  2023-507062-34-00 7 2020-08-07 "High-Risk large B-Cell lymphoma"
• Phase I/II, First in Human, Dose Escalation Trial of TL-895 Monotherapy in Subjects with Relapsed/Refractory B-Cell Malignancies and Expansi … Ended
  2024-516691-14-00 7 2021-01-05 "B Cell Malignancies and Chronic Lymphocytic Leukemia or Smal"
• An Early Phase Study with the Drug LOXO-305 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL … Ended
  2023-509270-37-00 7 2019-10-10 "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL"

Showing 1–9 of 9 trials